Black Diamond Therapeutics, Inc. (BDTX)

Last Closing Price: 3.10 (2026-04-23)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Black Diamond Therapeutics, Inc. (BDTX) had Net Income of $22.37M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$70.00M
Net Income
$22.37M
--
$70.00M
$57.48M
$12.52M
$9.85M
$22.37M
$22.37M
$22.37M
$22.37M
$22.37M
$22.37M
$12.52M
$12.85M
56.87M
57.56M
$0.39
$0.39
Balance Sheet Financials
$132.44M
$0.36M
$10.57M
$143.01M
$15.73M
--
$15.07M
$30.80M
$112.21M
$112.21M
$112.21M
57.14M
Cash Flow Statement Financials
$29.61M
$-44.91M
$-0.15M
$37.26M
$21.82M
$-15.44M
$6.63M
--
--
Fundamental Metrics & Ratios
8.42
--
--
--
--
100.00%
17.89%
17.89%
18.35%
31.95%
31.95%
$29.64M
--
--
--
0.49
--
--
--
19.93%
19.93%
15.64%
19.93%
$1.96
$0.51
$0.51